Kellanova Current Deferred Revenue vs Other Stockholder Equity Analysis
K Stock | USD 57.73 0.72 1.23% |
Kellanova financial indicator trend analysis is infinitely more than just investigating Kellanova recent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Kellanova is a good investment. Please check the relationship between Kellanova Current Deferred Revenue and its Other Stockholder Equity accounts. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Kellanova. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in industry. For more information on how to buy Kellanova Stock please use our How to buy in Kellanova Stock guide.
Current Deferred Revenue vs Other Stockholder Equity
Current Deferred Revenue vs Other Stockholder Equity Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Kellanova Current Deferred Revenue account and Other Stockholder Equity. At this time, the significance of the direction appears to have weak relationship.
The correlation between Kellanova's Current Deferred Revenue and Other Stockholder Equity is 0.32. Overlapping area represents the amount of variation of Current Deferred Revenue that can explain the historical movement of Other Stockholder Equity in the same time period over historical financial statements of Kellanova, assuming nothing else is changed. The correlation between historical values of Kellanova's Current Deferred Revenue and Other Stockholder Equity is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Current Deferred Revenue of Kellanova are associated (or correlated) with its Other Stockholder Equity. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Other Stockholder Equity has no effect on the direction of Current Deferred Revenue i.e., Kellanova's Current Deferred Revenue and Other Stockholder Equity go up and down completely randomly.
Correlation Coefficient | 0.32 |
Relationship Direction | Positive |
Relationship Strength | Very Weak |
Current Deferred Revenue
Revenue that has been collected but not yet earned, typically from prepaid service contracts or subscriptions. This amount is considered a liability until the service is provided or the subscription period ends.Other Stockholder Equity
Most indicators from Kellanova's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Kellanova current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Kellanova. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in industry. For more information on how to buy Kellanova Stock please use our How to buy in Kellanova Stock guide.At this time, Kellanova's Selling General Administrative is quite stable compared to the past year. Tax Provision is expected to rise to about 318.4 M this year, although Enterprise Value Multiple will most likely fall to 9.88.
2021 | 2022 | 2023 | 2024 (projected) | Gross Profit | 4.6B | 4.6B | 13.1B | 13.8B | Total Revenue | 14.2B | 15.3B | 13.1B | 10.6B |
Kellanova fundamental ratios Correlations
Click cells to compare fundamentals
Kellanova Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Kellanova fundamental ratios Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Total Assets | 17.6B | 18.0B | 18.2B | 18.5B | 15.6B | 10.7B | |
Short Long Term Debt Total | 8.5B | 8.1B | 7.7B | 7.2B | 6.5B | 4.8B | |
Other Current Liab | 1.6B | 1.1B | 763M | 1.9B | 1.8B | 1.8B | |
Total Current Liabilities | 4.8B | 5.2B | 5.3B | 6.3B | 5.1B | 3.2B | |
Total Stockholder Equity | 2.7B | 3.1B | 3.7B | 3.9B | 3.2B | 2.1B | |
Property Plant And Equipment Net | 4.2B | 4.4B | 4.5B | 4.4B | 3.9B | 3.3B | |
Net Debt | 8.1B | 7.7B | 7.4B | 6.9B | 6.3B | 4.5B | |
Retained Earnings | 7.9B | 8.3B | 9.0B | 9.2B | 8.8B | 4.8B | |
Cash | 397M | 435M | 286M | 299M | 274M | 281.4M | |
Non Current Assets Total | 14.1B | 14.5B | 14.8B | 14.3B | 12.3B | 8.3B | |
Non Currrent Assets Other | 908M | 1.2B | 1.5B | 1.3B | 961M | 663.9M | |
Cash And Short Term Investments | 397M | 435M | 286M | 299M | 274M | 281.4M | |
Net Receivables | 1.6B | 1.5B | 1.5B | 1.7B | 1.6B | 1.0B | |
Common Stock Shares Outstanding | 345.6M | 348M | 343M | 345M | 344M | 325.0M | |
Liabilities And Stockholders Equity | 17.6B | 18.0B | 18.2B | 18.5B | 15.6B | 10.7B | |
Non Current Liabilities Total | 9.5B | 9.1B | 8.6B | 7.8B | 7.2B | 5.3B | |
Inventory | 1.2B | 1.3B | 1.4B | 1.8B | 1.2B | 874.5M | |
Other Current Assets | 232M | 226M | 221M | 383M | 245M | 246.2M | |
Other Stockholder Equity | (3.8B) | (3.6B) | (3.7B) | (3.7B) | (3.7B) | (3.5B) | |
Total Liab | 14.3B | 14.4B | 14.0B | 14.1B | 12.3B | 8.5B | |
Total Current Assets | 3.4B | 3.5B | 3.4B | 4.2B | 3.3B | 2.4B | |
Short Term Debt | 841M | 846M | 965M | 1.4B | 905M | 955.0M | |
Intangible Assets | 2.6B | 2.5B | 2.4B | 2.3B | 1.9B | 2.0B | |
Accounts Payable | 2.4B | 2.5B | 2.6B | 3.0B | 2.3B | 1.2B | |
Property Plant And Equipment Gross | 4.2B | 4.4B | 4.5B | 4.4B | 8.2B | 8.6B | |
Accumulated Other Comprehensive Income | (1.4B) | (1.7B) | (1.7B) | (1.7B) | (2.0B) | (2.1B) | |
Other Liab | 1.8B | 1.9B | 1.9B | 1.9B | 2.1B | 1.4B | |
Other Assets | 1.1B | 6.2B | 1.7B | 1.5B | 1.7B | 1.1B | |
Long Term Debt | 7.2B | 6.7B | 6.3B | 5.3B | 5.1B | 5.7B | |
Good Will | 5.9B | 5.8B | 5.8B | 5.7B | 5.2B | 4.7B | |
Treasury Stock | (4.7B) | (4.6B) | (4.7B) | (4.7B) | (4.2B) | (4.0B) | |
Property Plant Equipment | 3.6B | 3.7B | 4.5B | 4.4B | 5.1B | 3.7B | |
Current Deferred Revenue | 596M | 776M | 1.0B | 150M | 85M | 80.8M | |
Net Tangible Assets | (5.3B) | (4.7B) | (4.5B) | (3.6B) | (3.2B) | (3.4B) | |
Noncontrolling Interest In Consolidated Entity | 567M | 524M | 495M | 434M | 499.1M | 524.1M | |
Retained Earnings Total Equity | 7.9B | 8.3B | 9.0B | 9.2B | 10.6B | 7.8B |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Kellanova. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in industry. For more information on how to buy Kellanova Stock please use our How to buy in Kellanova Stock guide.You can also try the Portfolio Dashboard module to portfolio dashboard that provides centralized access to all your investments.
Complementary Tools for Kellanova Stock analysis
When running Kellanova's price analysis, check to measure Kellanova's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Kellanova is operating at the current time. Most of Kellanova's value examination focuses on studying past and present price action to predict the probability of Kellanova's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Kellanova's price. Additionally, you may evaluate how the addition of Kellanova to your portfolios can decrease your overall portfolio volatility.
Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
Content Syndication Quickly integrate customizable finance content to your own investment portal | |
Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
Money Managers Screen money managers from public funds and ETFs managed around the world |
Is Kellanova's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Kellanova. If investors know Kellanova will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Kellanova listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.13) | Dividend Share 2.34 | Earnings Share 2.25 | Revenue Per Share 38.359 | Quarterly Revenue Growth (0.17) |
The market value of Kellanova is measured differently than its book value, which is the value of Kellanova that is recorded on the company's balance sheet. Investors also form their own opinion of Kellanova's value that differs from its market value or its book value, called intrinsic value, which is Kellanova's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Kellanova's market value can be influenced by many factors that don't directly affect Kellanova's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Kellanova's value and its price as these two are different measures arrived at by different means. Investors typically determine if Kellanova is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Kellanova's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.